Edelweiss MSCI India Domestic & World Healthcare 45 Index Growth Direct Plan
SIP amount
Min. ₹100
Lumpsum amount
Min. ₹100

Edelweiss MSCI India Domestic & World Healthcare 45 Index Growth Direct Plan

NAV
₹19.8432
-0.87%
(20 Dec)
AUM
154 Cr
TER
0.5%
Risk
Very High Risk
Insights
Net Asset Value (NAV) is above its 200 days moving average
Total Expense Ratio (TER) is in the top 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+31.8%
+31.8%
+29.7%
+29.4%
+29.0%
3Y
+24.6%
+16.6%
+24.9%
+24.9%
+24.6%
5Y
+30.3%
NA
NA
+28.3%
NA
ALL
+29.6%
+17.9%
+26.1%
+28.7%
+26.0%
VOL
20.1%
11.8%
16.4%
18.8%
16.4%
TER
0.4%
0.5%
0.4%
0.3%
0.3%
AUM
₹845 Cr
₹154 Cr
₹285 Cr
₹1,986 Cr
₹1,636 Cr
INFO
1.48
1.52
1.60
1.52
1.58
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
Edelweiss MSCI India Domestic & World Healthcare 45 Index (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 31st Oct
Top holdings
Sun Pharmaceuticals Industries Ltd
13.3%
Cipla Ltd
6.1%
Max Healthcare Institute Ltd Ordinary Shares
5.9%
Dr Reddy's Laboratories Ltd
5.6%
Apollo Hospitals Enterprise Ltd
5.3%
Divi's Laboratories Ltd
5.3%
Eli Lilly and Co
5.1%
Lupin Ltd
3.7%
Johnson & Johnson
2.9%
Aurobindo Pharma Ltd
2.8%
Top industry exposure
Healthcare
100.0%
Other information
Minimum SIP
₹100
Minimum lumpsum
₹100
Additional lumpsum
₹100
Portfolio turnover
-
Lock-in period
-
Exit load
No exit load
Fund objective
The Scheme will invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.
Fund manager(s)
Bhavesh Jain
Amit Vora

FAQs